A company that has been acquired by Paragraf and was involved in graphene sensing solutions.

Cardea Bio (part of Paragraf®)

Cardea Bio

Paragraf®

Cardea Bio is the world’s only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit). The BPU is the first and only semiconductor capable of translating real-time streams of multiomics signals into digital information.

Through the BPU™ platform, Cardea's long-term vision is to democratize access to the biosignals and insights behind the most advanced technology on our planet: Nature and biology. The Internet of Biology is that way becoming possible. 

Cardea is headquartered in San Diego and has additional activity in Los Angeles. Cardea is a 100% American developed and built biocompatible semiconductor technology for applications across a variety of sectors including human health, agriculture, molecular diagnostics, biotechnology, environmental monitoring, and animal health.

In May 2023, Cardea Bio became part of Paragraf, who has revolutionized graphene electronic device manufacturing with its pioneering scalable approach, making it the world's first company to achieve this feat. The acquisition of Cardea Bio and creation of Paragraf USA will enable Paragraf to offer a new generation of biosensing devices that will deliver the features and result sensitivity of existing lab-based instruments, with the rapid response and simple ease of use required to enable handheld, real-time, in the field use.

Sand Hill Angels

Bill & Melinda Gates Foundation

Taihill Venture

3E Bioventures

Lifespan Investments

Photon Fund

Serra Ventures

Skylight Investment

Table Mountain Ventures

Foothill Ventures

Agilent Technologies

Have you started following Paragraf® yet? Don't miss out on future news about Cardea, now part of Paragraf. This page is no longer active - follow us now:

https://lnkd.in/eQSWrm9E
https://lnkd.in/emXmBsqG
https://lnkd.in/eHZcP56c

Cardea Bio joined forces with Paragraf in May this year, combining our expertise in graphene electronic device manufacturing and life science applications. As the world's first company to achieve a scalable approach in this field, Paragraf has revolutionized the industry. We are thrilled to embark on this shared journey and will soon close the Cardea Bio account. 

Continue to stay updated on Cardea Bio and Paragraf news by following us at Paragraf®.

www.paragraf.com

Have you checked out Paragraf's Knowledge Centre? Our blogs and articles cover topics such as quantum computing, EV batteries, biosensors and everything about graphene. 

Now that Cardea has joined Paragraf, this LinkedIn page will be inactive. Don't miss out on new content - follow Paragraf®.

https://lnkd.in/eBwF_jYR

#blogs #quantumcomputing #ev #evbatteries #biosensors #graphene

CARD

COM:CARDEABIO

Cardea Bio

name

homepage url

country

linkedin url

employee count

sector

industry

monthly webtraffic

Description

peer of

Metrics